期刊文献+

基于Web of Science探讨全球阿德福韦酯相关低磷血症研究

Exploring Global Adefovir Dipivoxil-Induced Hypophosphatemia Based on Web of Science
下载PDF
导出
摘要 目的了解阿德福韦酯相关低磷血症的研究现状。方法利用Web of Science数据库检索阿德福韦酯相关低磷血症文献,检索日期截至2018年7月31日,分别从文献发表的年份、引用率、地域及国家、刊载期刊等方面进行统计与分析。结果2004年至2012年为稳定期(每年发表的文献不超过5篇),2013年至2015年为上升期,2016年至2018年发表量逐年下降;亚洲发表最多(48篇),其中发表最多的国家为中国(33篇);《中国骨质疏松杂志》刊载最多(4篇)。结论阿德福韦酯会引起低磷血症,应采取有效措施进行防治。 Objective To understand the research status quo of global adefovir dipivoxil-induced hypophosphatemia. Methods Publications related to adefovir dipivoxil-induced hypophosphatemia were searched with Web of Science database. The searching date was until31 st,July 2018. Statistical analysis of published years,citation rates,regions and countries,journals of publications were performed.Results The years from 2004 to 2012 were the stable period,with each year no more than 5 articles published. The years from 2013 to 2015 were the rising period. From 2016 to 2018,the number of publications decreased year by year. Asia had the largest number of publications( 48 articles),and the most published country was China( 33 articles). The Chinese Journal of Osteoporosis published the most publications( 4 articles). Conclusion Adefovir dipivoxil would induce hypophosphatemia and effective measures should be taken to avoid its occurrence.
作者 黄金路 傅瑶 孟祥乐 万丽丽 霍炎 卢进 干润 郭澄 HUANG Jinlu;FU Yao;MENG Xiangle;WAN Lili;HUO Yan;LU Jin;GAN Run;GUO Cheng(Department of Pharmacy,Shanghai Jiaotong University Affiliated Sixth People's Hospital,Shanghai,China 200233;The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou,Henan,China 450000)
出处 《中国药业》 CAS 2020年第1期1-3,共3页 China Pharmaceuticals
基金 国家自然科学基金[81603082]
关键词 阿德福韦酯 慢性乙型肝炎 低磷血症 文献计量学 adefovir dipivoxil chronic hepatitis B hypophosphatemia bibliometrics
  • 相关文献

参考文献13

二级参考文献103

  • 1Masami Minemura,Yoshiharu Tokimitsu,Kazuto Tajiri,Yasuhiro Nakayama,Kengo Kawai,Hiroshi Kudo,Katsuharu Hirano,Yoshinari Atarashi,Yutaka Yata,Satoshi Yasumura,Terumi Takahara,Toshiro Sugiyama.Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil[J].World Journal of Hepatology,2010,2(12):442-446. 被引量:13
  • 2李运景,侯汉清,裴新涌.引文编年可视化软件HistCite介绍与评价[J].图书情报工作,2006,50(12):135-138. 被引量:84
  • 3郭萍,李成建,田玉琴.果糖二磷酸钠不良反应[J].中国误诊学杂志,2007,7(3):659-659. 被引量:4
  • 4SIEST G, JEANNESSON E, BERRAHMOUNE H, et al. Phar- macogenomics and drug response in cardiovascular disorders[ J]. Pharmacogenomics, 2004, 5 (7) : 779 - 802.
  • 5PRICEEVA DA. Pharmacogenetics [ J ]. Acta Genet Med Gemellol, 1962,11(3) :335.
  • 6ANGST MS, PHILLLIPS NG, DROVER DR, et al. Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability [J]. Twin Res Human Genet, 2010,13(5) :412 -425.
  • 7MARSHALL A. Genset-Abbott deal heralds pharmacogenomics era [ J ]. Nat Biotechnol, 1997,15 ( 9 ) : 829 - 830.
  • 8EVANS WE, RELLING MV. Pharmacogenomics: translating functional genomics into rational therapeutics [ J ]. Science, 1999, 286(5439) :487 -491.
  • 9ROSES AD. Pharmacogenetics and the practice of medicine[J]. Nature, 2000,405 ( 6788 ) : 857 - 865.
  • 10SUBRAMANIAN GA, DAMS MD, VENTER JC, et al. Implica- tions of the human genome for understanding human biology and medicine [ J ]. JAMA, 2001,286 ( 18 ) : 2296 - 2307.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部